Indication and benefit of upfront hematopoietic stem cell transplantation for T-cell lymphoblastic lymphoma in the era of ALL-type induction therapies.

Sci Rep · 2020 · PMC7722931 · PMID 33293600

Europe PMC DOI

hedged sentence

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

borderline significancep = 0.06so close (0.05 < p ≤ 0.1)

3 B), while standard-disease patients showed lower relapse with borderline significance when compared with advanced-disease patients (60.0%; 95% CI 21.7–84.3% vs. 27.3%; 95% CI 5.7–55.4%; p = 0.06) (Fig. 3 C).

also in 7,017 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.